首页 > 最新文献

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna最新文献

英文 中文
Patient-Centered Medicine 以病人为中心的医学
{"title":"Patient-Centered Medicine","authors":"","doi":"10.32388/kfcob4","DOIUrl":"https://doi.org/10.32388/kfcob4","url":null,"abstract":"","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69633580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer chemotherapy. 癌症化疗。
G. Secchi
(1) In June 2006 the French National Cancer Institute published the results of a survey of eating difficulties among 1843 patients receiving cancer chemotherapy; (2) More than one-third of patients said they had less appetite than before ("far less" in 13% of cases). About half of patients said they had noticed a change in their sensation of thirst; (3) Half of patients who had been receiving treatment for at least 6 months said they had lost weight; (4) Half of patients found food tasted different. 43% of patients found certain odours unbearable, especially perfumes and tobacco. One-third of patients said the smell of the treatment room made them nauseous. Many patients found mealtimes unpleasant, sometimes even a source of anxiety; (5) In practice, these eating difficulties should be taken into account when assessing the risk-benefit balance of cancer treatments. When a treatment needs to be pursued, patients should be helped to find ways of making food more palatable, the treatment room should be well ventilated, and perfumes should not be used.
作者论述了正确合理的抗肿瘤化疗的生物学依据和临床基本原则。化疗的有效性主要取决于以下因素:1)肿瘤细胞的动力学阶段,2)药物在肿瘤块内的渗透,3)肿瘤细胞在药理学庇护所中的分离,4)耐药细胞表型的存在。因此,适当的化疗必须:1)早期开始,肿瘤小,耐药细胞和G0细胞数量少;2)同时使用几种药物作用于处于不同复制阶段的细胞,没有重叠毒性和交叉抗性;3)在一个周期和另一个周期之间以高剂量和最佳时间间隔使用,以便尽可能多地破坏肿瘤细胞,以防止肿瘤的再生和耐药细胞株的发展。
{"title":"Cancer chemotherapy.","authors":"G. Secchi","doi":"10.1201/b13234-61","DOIUrl":"https://doi.org/10.1201/b13234-61","url":null,"abstract":"(1) In June 2006 the French National Cancer Institute published the results of a survey of eating difficulties among 1843 patients receiving cancer chemotherapy; (2) More than one-third of patients said they had less appetite than before (\"far less\" in 13% of cases). About half of patients said they had noticed a change in their sensation of thirst; (3) Half of patients who had been receiving treatment for at least 6 months said they had lost weight; (4) Half of patients found food tasted different. 43% of patients found certain odours unbearable, especially perfumes and tobacco. One-third of patients said the smell of the treatment room made them nauseous. Many patients found mealtimes unpleasant, sometimes even a source of anxiety; (5) In practice, these eating difficulties should be taken into account when assessing the risk-benefit balance of cancer treatments. When a treatment needs to be pursued, patients should be helped to find ways of making food more palatable, the treatment room should be well ventilated, and perfumes should not be used.","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 1","pages":"159-60"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65977040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen. 抗菌/通透性增加蛋白抗中性粒细胞胞浆抗体(ANCA)与相关疾病:新出现的ANCA靶抗原的临床相关性
Lorenzo Emmi, Alexia Chatzipetrou
{"title":"Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.","authors":"Lorenzo Emmi, Alexia Chatzipetrou","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 4","pages":"205-8"},"PeriodicalIF":0.0,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25969743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches. 青少年特发性关节炎:临床和治疗方法的更新。
Laura Quarta, Addolorata Corrado, Nadia Melillo, Francesco Paolo Cantatore

Juvenile idiopathic arthritis represents a heterogeneous group of autoimmune diseases. It arises before 16 years of age and lasts more than 6 months. We can distinguish many arthritis sub-types. A serious problem in juvenile idiopathic arthritis is skeletal growth retardation, osteopenia and greater risk of developing fractures. Juvenile idiopathic arthritis diagnosis is an exclusion diagnosis. Many conditions can simulate it. First-choice drugs in juvenile idiopathic arthritis treatment are nonsteroidal anti-inflammatory drugs, analgesic and antipyretic drugs. The second-choice drugs are "slow-acting" antirheumatic drugs, like methotrexate. The use of glucocorticoids is strongly influenced by their side effects, in particular the inhibition of statural growth and the premature appearance of osteoporosis. Recent findings on the central role of tumor necrosis factor-alpha, in particular damage pathogenesis in the course of juvenile idiopathic arthritis, have permitted the development of new therapeutic strategies (infliximab, etanercept), aimed at blocking this cytokine.

青少年特发性关节炎是一种异质性的自身免疫性疾病。发病年龄在16岁之前,持续时间超过6个月。我们可以区分许多关节炎亚型。在青少年特发性关节炎的一个严重问题是骨骼生长迟缓,骨质减少和更大的风险发展骨折。青少年特发性关节炎的诊断是一种排除性诊断。许多条件都可以模拟它。治疗青少年特发性关节炎的首选药物是非甾体类抗炎药、镇痛药和解热药。第二种选择是“慢效”抗风湿药,如甲氨蝶呤。糖皮质激素的使用受到其副作用的强烈影响,特别是对身材生长的抑制和骨质疏松症的过早出现。最近关于肿瘤坏死因子- α的核心作用的发现,特别是在青少年特发性关节炎过程中的损伤发病机制,已经允许开发新的治疗策略(英夫利昔单抗,依那西普),旨在阻断这种细胞因子。
{"title":"Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches.","authors":"Laura Quarta,&nbsp;Addolorata Corrado,&nbsp;Nadia Melillo,&nbsp;Francesco Paolo Cantatore","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Juvenile idiopathic arthritis represents a heterogeneous group of autoimmune diseases. It arises before 16 years of age and lasts more than 6 months. We can distinguish many arthritis sub-types. A serious problem in juvenile idiopathic arthritis is skeletal growth retardation, osteopenia and greater risk of developing fractures. Juvenile idiopathic arthritis diagnosis is an exclusion diagnosis. Many conditions can simulate it. First-choice drugs in juvenile idiopathic arthritis treatment are nonsteroidal anti-inflammatory drugs, analgesic and antipyretic drugs. The second-choice drugs are \"slow-acting\" antirheumatic drugs, like methotrexate. The use of glucocorticoids is strongly influenced by their side effects, in particular the inhibition of statural growth and the premature appearance of osteoporosis. Recent findings on the central role of tumor necrosis factor-alpha, in particular damage pathogenesis in the course of juvenile idiopathic arthritis, have permitted the development of new therapeutic strategies (infliximab, etanercept), aimed at blocking this cytokine.</p>","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 4","pages":"211-7"},"PeriodicalIF":0.0,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25969744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Depression in patients with cardiovascular disease]. 【心血管疾病患者的抑郁】。
Fabio Lugoboni, Gianluca Quaglio, Paolo Mezzelani, Alessandro Lechi

Cardiovascular disease and depression, which is frequently encountered in developed countries, are unexpectedly linked and someway interdependent. Although it has been proven that major depression is a risk factor for cardiovascular disease, it is also true that cardiovascular disease may often cause depression. This article provides epidemiological data regarding this phenomenon and focuses on the mechanisms and causes that link these apparently unrelated pathologies. The diagnosis of depression and the difficulty in recognizing it as such are reviewed and several tests useful for this purpose are presented. Finally, the most common antidepressants particularly suitable for cardiac patients are examined along with any possible interactions between these drugs and those currently used for treatment of cardiovascular disease.

发达国家经常遇到的心血管疾病和抑郁症出乎意料地相互联系,并在某种程度上相互依存。虽然已经证明重度抑郁症是心血管疾病的危险因素,但心血管疾病也可能经常导致抑郁症,这也是事实。本文提供了有关这一现象的流行病学数据,并着重于将这些显然不相关的病理联系起来的机制和原因。本文回顾了抑郁症的诊断和识别抑郁症的困难,并介绍了几种用于此目的的测试。最后,特别适用于心脏病患者的最常见的抗抑郁药,以及这些药物与目前用于治疗心血管疾病的药物之间的任何可能的相互作用进行了检查。
{"title":"[Depression in patients with cardiovascular disease].","authors":"Fabio Lugoboni,&nbsp;Gianluca Quaglio,&nbsp;Paolo Mezzelani,&nbsp;Alessandro Lechi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cardiovascular disease and depression, which is frequently encountered in developed countries, are unexpectedly linked and someway interdependent. Although it has been proven that major depression is a risk factor for cardiovascular disease, it is also true that cardiovascular disease may often cause depression. This article provides epidemiological data regarding this phenomenon and focuses on the mechanisms and causes that link these apparently unrelated pathologies. The diagnosis of depression and the difficulty in recognizing it as such are reviewed and several tests useful for this purpose are presented. Finally, the most common antidepressants particularly suitable for cardiac patients are examined along with any possible interactions between these drugs and those currently used for treatment of cardiovascular disease.</p>","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 4","pages":"224-32"},"PeriodicalIF":0.0,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25970232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Soft tissue infection caused by Mycobacterium chelonae following a liposculpture and lipofilling procedure. 在脂质雕刻和脂质填充手术后,由龟分枝杆菌引起的软组织感染。
Maddalena Giannella, Eleonora Pistella, Antonio Perciaccante, Mario Venditti

Skin and soft tissue infections that usually follow minor traumatic events or surgical procedures are caused by a wide spectrum of bacteria. We describe a soft tissue infection caused by a Mycobacterium chelonae in an immunocompetent patient who underwent liposculpture and lipofilling of the gluteal-trochanteric region, emphasizing the importance of clinical suspicion and effective treatment of infection.

通常在轻微创伤事件或外科手术后发生的皮肤和软组织感染是由多种细菌引起的。我们描述了一个由龟分枝杆菌引起的软组织感染的免疫功能正常的病人谁接受脂肪雕刻和脂肪填充臀-粗隆区,强调临床怀疑和有效治疗感染的重要性。
{"title":"Soft tissue infection caused by Mycobacterium chelonae following a liposculpture and lipofilling procedure.","authors":"Maddalena Giannella,&nbsp;Eleonora Pistella,&nbsp;Antonio Perciaccante,&nbsp;Mario Venditti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Skin and soft tissue infections that usually follow minor traumatic events or surgical procedures are caused by a wide spectrum of bacteria. We describe a soft tissue infection caused by a Mycobacterium chelonae in an immunocompetent patient who underwent liposculpture and lipofilling of the gluteal-trochanteric region, emphasizing the importance of clinical suspicion and effective treatment of infection.</p>","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 4","pages":"245-7"},"PeriodicalIF":0.0,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25970234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature]. p-ANCA(杀菌/通透性增加蛋白)阳性血管炎加重支气管扩张。病例报告及文献综述]。
Maurizio Benucci, Gabriele Nenci, Gianni Taccetti, Aurelio Rosso, Chiara Beltrame, Carlo Cappelletti, Mariangela Manfredi

A 67-year-old woman was hospitalized with recurrent fever, arthralgia and erythema of the arms and legs. She had suffered from bronchiectasis for the previous 4 years, and Pseudomonas was persistently detected in her sputum. During the course of her illness, she developed distal sensitive and motor polyneuropathy. Serum test was positive for myeloperoxidase and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies. Nerve biopsy showed vasculitis infiltration of the vasa nervorum. She started immunoglobulin therapy, and after methylprednisolone and pulse cyclophosphamide therapy once monthly for 6 months she showed a good response and a reduction in symptoms.

一名67岁妇女因反复发热、关节痛和四肢红斑住院。既往支气管扩张4年,痰中持续检出假单胞菌。在她的病程中,她发展为远端敏感和运动多发性神经病。血清检测髓过氧化物酶和杀菌/增透蛋白抗中性粒细胞胞浆抗体阳性。神经活检显示血管炎浸润神经血管。她开始免疫球蛋白治疗,甲泼尼龙和环磷酰胺脉冲治疗每月一次,6个月后,她表现出良好的反应和症状减轻。
{"title":"[Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature].","authors":"Maurizio Benucci,&nbsp;Gabriele Nenci,&nbsp;Gianni Taccetti,&nbsp;Aurelio Rosso,&nbsp;Chiara Beltrame,&nbsp;Carlo Cappelletti,&nbsp;Mariangela Manfredi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 67-year-old woman was hospitalized with recurrent fever, arthralgia and erythema of the arms and legs. She had suffered from bronchiectasis for the previous 4 years, and Pseudomonas was persistently detected in her sputum. During the course of her illness, she developed distal sensitive and motor polyneuropathy. Serum test was positive for myeloperoxidase and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies. Nerve biopsy showed vasculitis infiltration of the vasa nervorum. She started immunoglobulin therapy, and after methylprednisolone and pulse cyclophosphamide therapy once monthly for 6 months she showed a good response and a reduction in symptoms.</p>","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 4","pages":"258-61"},"PeriodicalIF":0.0,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25970239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Antiphospholipid syndrome and venous thromboembolism: the role of congenital thrombophilia]. [抗磷脂综合征和静脉血栓栓塞:先天性血栓的作用]。
Daniela Poli, Gian Franco Gensini

The antiphospholipid syndrome is associated with complications of pregnancy or venous or arterial thrombosis in the presence of antiphospholipid antibodies. Venous thromboembolism is the most common clinical feature. Pathogenetic mechanisms underlying the syndrome are not completely understood and several hypotheses have been raised. Secondary prophylaxis after venous thromboembolism episodes requires oral anticoagulants (prothrombin time-international normalized ratio 2-3) for 6 to 12 months. More intensive anticoagulant regimens are indicated in case of recurrence. A longer or life-long course of treatment is indicated in patients with recurrent or life-threatening events or in the presence of high titers of antiphospholipid antibodies. Among risk factors for venous thromboembolism, inherited thrombophilia is recently described, such as defects of the physiological coagulation inhibitors, genetic mutations of factor V and factor II of the coagulation cascade and hyperhomocysteinemia. High levels of factor VIII, factor IX and lipoprotein(a) have recently been proposed as new risk factors for venous thromboembolism. The coexistence of inherited thrombophilia seems to enhance the thrombogenic risk, in particular in the venous vascular bed. The new insights into the diagnosis of inherited thrombophilia could allow a better evaluation of the thrombotic risk, leading to tailor the prophylactic strategy.

抗磷脂综合征与妊娠并发症或存在抗磷脂抗体的静脉或动脉血栓形成有关。静脉血栓栓塞是最常见的临床特征。该综合征的发病机制尚不完全清楚,提出了几种假说。静脉血栓栓塞发作后的二级预防需要口服抗凝剂(凝血酶原时间-国际标准化比率2-3)6至12个月。复发时需要更强化的抗凝治疗方案。复发性或危及生命的事件或存在高滴度抗磷脂抗体的患者需要更长的或终生疗程。在静脉血栓栓塞的危险因素中,最近发现了遗传性血栓性疾病,如生理性凝血抑制剂的缺陷、凝血级联因子V和因子II的基因突变以及高同型半胱氨酸血症。高水平的因子VIII、因子IX和脂蛋白(a)最近被认为是静脉血栓栓塞的新危险因素。遗传性血栓病的共存似乎增加了血栓形成的风险,特别是在静脉血管床。对遗传性血栓病诊断的新见解可以更好地评估血栓形成风险,从而制定预防策略。
{"title":"[Antiphospholipid syndrome and venous thromboembolism: the role of congenital thrombophilia].","authors":"Daniela Poli,&nbsp;Gian Franco Gensini","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The antiphospholipid syndrome is associated with complications of pregnancy or venous or arterial thrombosis in the presence of antiphospholipid antibodies. Venous thromboembolism is the most common clinical feature. Pathogenetic mechanisms underlying the syndrome are not completely understood and several hypotheses have been raised. Secondary prophylaxis after venous thromboembolism episodes requires oral anticoagulants (prothrombin time-international normalized ratio 2-3) for 6 to 12 months. More intensive anticoagulant regimens are indicated in case of recurrence. A longer or life-long course of treatment is indicated in patients with recurrent or life-threatening events or in the presence of high titers of antiphospholipid antibodies. Among risk factors for venous thromboembolism, inherited thrombophilia is recently described, such as defects of the physiological coagulation inhibitors, genetic mutations of factor V and factor II of the coagulation cascade and hyperhomocysteinemia. High levels of factor VIII, factor IX and lipoprotein(a) have recently been proposed as new risk factors for venous thromboembolism. The coexistence of inherited thrombophilia seems to enhance the thrombogenic risk, in particular in the venous vascular bed. The new insights into the diagnosis of inherited thrombophilia could allow a better evaluation of the thrombotic risk, leading to tailor the prophylactic strategy.</p>","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 4","pages":"218-23"},"PeriodicalIF":0.0,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25970231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital care for frail, complex elders: more than a matter of appropriateness. 对体弱多病的老年人的医院护理:不仅仅是合适的问题。
Mauro Di Bari, Giulio Masotti
{"title":"Hospital care for frail, complex elders: more than a matter of appropriateness.","authors":"Mauro Di Bari,&nbsp;Giulio Masotti","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 4","pages":"209-10"},"PeriodicalIF":0.0,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25969745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Characteristics of patients admitted to a Division of Internal Medicine. Is hospital the best setting of care?]. [内科住院病人的特点。]医院是护理的最佳场所吗?
Maria Angela Becchi, Francesco Bellelli, Marco Clarizio, Nicola Carulli

The aim of this study was to describe the characteristics of institutionalized patients, the patterns of admission, hospital stay and discharge and the extent of resource utilization before, during and after hospitalization, in an Acute Division of Internal Medicine of a university hospital. All adult patients admitted to the division were consecutively enrolled during a 3-month study period. Patients underwent a multidimensional assessment and data collection concerning admission and discharge patterns, resource utilization, and discharge diagnosis. Three hundred and eighteen patients, with an average age of 73.8 years, entered in the study; the rate of patients both affected by severe cognitive and functional impairment was high (29.9%); 3-4 comorbidity classes were estimated in 70.8% of patients; the most frequent diagnoses at discharge were gastrointestinal (major diagnostic category 6), liver and pancreas diseases (major diagnostic category 7); despite the high rate of comorbidity and severity of illness, the average diagnosis-related groups was low (1.15 +/- 0.59) and also the levels of nursing and personal care provided in the hospital were low (21 +/- 15 and 19 +/- 16, respectively). Median length of stay was 9 days and 3-4 comorbidity classes significantly prolonged hospitalization (p < 0.01). The main critical aspects concerning hospital admissions were the low rates of general practitioner requests of admission (26.7%), the high rates of unplanned readmissions (17.9%) and inappropriate recovery (12.6%). Concerning discharge, only 18.5% of patients had assisted discharges despite the high rates of patients with functional impairment; difficulties at discharge were estimated in 15.0% of patients. Our data suggest to improve the relation between hospital and primary health services in order to assure appropriateness of patient care and optimal use of a specialistic division.

本研究的目的是描述一所大学医院急诊科住院病人的特征、入院、住院和出院模式以及住院前、住院期间和住院后的资源利用程度。所有进入该科的成年患者在3个月的研究期间连续入组。患者接受了多维度的评估和数据收集,包括入院和出院模式、资源利用和出院诊断。318例患者入组,平均年龄73.8岁;同时伴有严重认知功能障碍的患者比例较高(29.9%);70.8%的患者共患3-4级;出院时最常见的诊断是胃肠道疾病(主要诊断类别6)、肝脏和胰腺疾病(主要诊断类别7);尽管合并症和疾病严重程度较高,但与诊断相关的平均分组较低(1.15 +/- 0.59),医院提供的护理和个人护理水平也较低(分别为21 +/- 15和19 +/- 16)。中位住院时间为9天,3-4个合并症类别显著延长住院时间(p < 0.01)。入院的主要关键方面是全科医生要求入院率低(26.7%),计划外再入院率高(17.9%)和不适当康复(12.6%)。出院方面,尽管功能障碍患者的比例很高,但只有18.5%的患者有辅助出院;估计有15.0%的患者在出院时出现困难。我们的数据建议改善医院和初级保健服务之间的关系,以确保适当的病人护理和最佳利用专科。
{"title":"[Characteristics of patients admitted to a Division of Internal Medicine. Is hospital the best setting of care?].","authors":"Maria Angela Becchi,&nbsp;Francesco Bellelli,&nbsp;Marco Clarizio,&nbsp;Nicola Carulli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The aim of this study was to describe the characteristics of institutionalized patients, the patterns of admission, hospital stay and discharge and the extent of resource utilization before, during and after hospitalization, in an Acute Division of Internal Medicine of a university hospital. All adult patients admitted to the division were consecutively enrolled during a 3-month study period. Patients underwent a multidimensional assessment and data collection concerning admission and discharge patterns, resource utilization, and discharge diagnosis. Three hundred and eighteen patients, with an average age of 73.8 years, entered in the study; the rate of patients both affected by severe cognitive and functional impairment was high (29.9%); 3-4 comorbidity classes were estimated in 70.8% of patients; the most frequent diagnoses at discharge were gastrointestinal (major diagnostic category 6), liver and pancreas diseases (major diagnostic category 7); despite the high rate of comorbidity and severity of illness, the average diagnosis-related groups was low (1.15 +/- 0.59) and also the levels of nursing and personal care provided in the hospital were low (21 +/- 15 and 19 +/- 16, respectively). Median length of stay was 9 days and 3-4 comorbidity classes significantly prolonged hospitalization (p < 0.01). The main critical aspects concerning hospital admissions were the low rates of general practitioner requests of admission (26.7%), the high rates of unplanned readmissions (17.9%) and inappropriate recovery (12.6%). Concerning discharge, only 18.5% of patients had assisted discharges despite the high rates of patients with functional impairment; difficulties at discharge were estimated in 15.0% of patients. Our data suggest to improve the relation between hospital and primary health services in order to assure appropriateness of patient care and optimal use of a specialistic division.</p>","PeriodicalId":77002,"journal":{"name":"Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna","volume":"20 4","pages":"233-44"},"PeriodicalIF":0.0,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25970233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1